Original language | English |
---|---|
Pages (from-to) | 1047-1049 |
Number of pages | 3 |
Journal | Clinical Microbiology and Infection |
Volume | 28 |
Issue number | 8 |
DOIs |
|
Publication status | Published - Aug 2022 |
The case for expanding worldwide access to point of care molecular drug susceptibility testing for isoniazid
Vanessa B. Vogensen, Richard M. Anthony, Huib A.M. Kerstjens, Simon Tiberi, Jurriaan E.M. de Steenwinkel, Onno W. Akkerman*
*Corresponding author for this work
Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
4
Citations
(Scopus)